Oral Anticoagulation Therapy

Cases and Clinical Correlation

Paperback Engels 2017 9783319546414
€ 159,59
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

Given the amount and complexity of information surrounding the the target specific oral anticoagulants a lengthy didactic educational format has the potential to be overwhelming to the reader and difficult to translate and apply to direct patient care. The proposed book will educate clinicians utilizing a series of clinical cases to simultaneously develop the readers’ knowledge base, problem-solving skills, and practically apply their new knowledge to a variety of clinical situations. These will be short focused case presentations that provide critical information and pose questions to the reader at key points in the decision making process. The cases will be relevant to what clinicians will encounter not only on a daily basis, but also reflective of scenarios that clinicians will not encounter regularly, but that they will have to act upon (e.g. a bleeding patient, patient scheduled for elective or emergent procedure, patient with changing renal function, patient on drugs that have a plausible yet unstudied drug interaction with a target specific oral anticoagulant etc).  Included in the case studies will be evidence-based discussions (with appropriate references) that provide immediate feedback on the different treatment alternatives that were offered.  The case studies will be designed to instruct the reader how to select and effectively utilize the most appropriate agent for a given clinical scenario. They will focus on key features of the target specific oral anticoagulants, what they have in common, how they are unique from each other, as well as illustrating the clinical decision process one should take when selecting an agent or managing a patient already receiving one of the target specific oral agents. ​ 

Specificaties

ISBN13:9783319546414
Taal:Engels
Bindwijze:paperback
Uitgever:Springer International Publishing

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

Table of Contents <p>Part I Introduction<br/> 1</p> <p>Part II Atrial Fibrillation<br/> 2: CHA<sub>2</sub>DS<sub>2</sub>VASc and HAS-BLED risk stratification tools<br/> 3: Male with priority of ischemic stroke reduction<br/> 4: Choosing an anticoagulant in an elderly patient<br/> 5: Patient with prior history of gastrointestinal hemorrhage<br/> 6: Patients with a history of intracranial hemorrhage<br/> 7: Concerns with anticoagulant adherence<br/> 8: Oral Anticoagulants in stable moderate Chronic Kidney Disease<br/> 9: Oral Anticoagulants in severe renal dysfunction<br/> 10: Oral Anticoagulants in patients with variable renal function<br/> 11: Patient with concomitant stable Coronary Artery Disease <br/> 12: Patient with concomitant acute venous thromboembolism <br/> 13: Patient with concomitant Mitral Valve Stenosis<br/> 14: Patient with concomitant Aortic Valve Stenosis<br/> <br/> Part III Warfarin management<br/> 15: Best practices for switching from stable warfarin<br/> 16: Patient-centered strategies for improving warfarin management</p> <p>Part IV Venous Thromboembolism (VTE)<br/> 17: Provoked versus unprovoked VTE<br/> 18: VTE prophylaxis in hip and knee replacement surgery<br/> 19: VTE prophylaxis in the intensive care unit<br/> 20: VTE and recent drug eluting stent placement<br/> 21: Acute VTE in a patient with moderate chronic kidney disease<br/> 22: Oral anticoagulation and duration in recurrent VTE<br/> 23: Pulmonary embolism (PE) with thrombolytic therapy<br/> <br/> Part V Acute Coronary Syndrome (ACS)<br/> 24: Patient on oral anticoagulant presenting with ACS<br/> 25: Oral anticoagulant therapy post-percutaneous coronary intervention<br/> 26: ST-segment elevation myocardial infarction (lytic candidate) on oral anticoagulant<br/> 27: ACS with bypass surgery<br/> <br/> Part VI Drug Interactions<br/> 28: Anticoagulant drug-drug interactions with CYP 3A4 inhibitors<br/> 29: Significance of P-glycoprotein (P-gp) drug-drug interactions<br/> 30: Considerations with pharmacodynamics drug-drug interactions<br/> 31: Management of direct oral anticoagulants with mixed P-gp/3A4 drug-drug interactions<br/> 32: Pharmacokinetic drug-drug interactions with warfarin</p> <p>Part VII Special Populations<br/> 33: Chronic Pain Management with anticoagulation<br/> 34: Anticoagulation management in atrial fibrillation catheter ablation<br/> 35: Anticoagulation management considerations for mechanical valves<br/> 36: Management of antiphospholipid antibody syndrome (APS)<br/> 37: VTE and Pregnancy<br/> 38: VTE in active Malignancy<br/> 39: Anticoagulation management in patients undergoing gastric bypass procedures<br/> 40: Patient presenting with minor bleeding<br/> 41: Patient presenting with major, life-threatening bleeding<br/> 42: Overdose of dabigatran<br/> <br/> <br/> </p> <p> </p>

Managementboek Top 100

€ 159,59
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Oral Anticoagulation Therapy